The Defibrillator Market is projected to reach $22.76 billion by 2031, at a CAGR of 6.9% from 2024 to 2031. Cardiac defibrillators are devices used to continuously monitor, regulate, and detect arrhythmias or irregular heartbeats in patients. These devices are available as implants, subcutaneous devices, and external devices.
The growth of the defibrillator market is driven by several factors, including the increasing burden of cardiovascular diseases and the rise in obesity, sedentary lifestyle, and excessive consumption of alcohol & caffeinated products, and technological advancements in defibrillator devices. Emerging economies are identified as one of the most important growth frontiers for medical devices, making them a factor for market growth. The increasing patient pool of individuals suffering from conditions such as cardiovascular diseases, deafness, orthopedic ailments, and other degenerative diseases can benefit greatly from newer technology-based implantable devices, especially for conditions wherein the pharmacological treatment is ineffective. According to the Population Reference Bureau (PRB), the largest regional percentage increase in population by 2050 will be in Africa, whose population can be expected to double from 1.1 billion in 2012 to approximately 2.3 billion in 2050. This is due to the assumption that sub-Saharan Africa’s total fertility rate (TFR, the average number of children per woman) will decline from 5.1 to approximately 3.0 by 2050. Thus, the increasing population, along with the rising burden of chronic cardiovascular diseases in developing countries like India, Brazil, and Indonesia, etc. are resulting in increasing healthcare expenditure, which proportionally drives the demand for cardioverter defibrillators and also serves as an opportunity for key players in emerging economies.
Cardiovascular diseases (CVD), which include coronary heart diseases, cerebrovascular diseases, and peripheral vascular diseases, are the leading causes of death globally, especially in the U.S. and other developed countries. The major risk factors include obesity and its consequences, such as dyslipidemia, hypertension, and insulin resistance, leading to diabetes. According to the American Heart Association (AHA), in 2020, approximately 19.1 million deaths were globally attributed to CVD. Moreover, cardiovascular diseases claim more lives each year than all forms of cancer and chronic lower respiratory disease combined.
Defibrillators are devices that are implanted inside or outside of the body, to be able to amend certain cardiac episodes such as cardiac arrhythmia. Most cardiac episodes are instigated by the rapid, chaotic activity of the heart, known as ventricular tachycardia (VT) or ventricular fibrillation (VF). Cardiac arrest is rescindable in most victims if treated within minutes, but the only effective treatment is the delivery of an electrical tremor. Several types of defibrillators are being used to control arrhythmia and prevent serious complications. For instance, in October 2023, Medtronic plc (Ireland) received the U.S. Food and Drug Administration (FDA) approval for the Aurora EV-IVD MRI SureScan and Epsila EV MRI SureScan defibrillation, which treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
Rising Geriatric Population in Emerging Economies
Emerging economies are widely recognized as one of the most important growth frontiers for medical devices. The increasing patient pool of individuals suffering from conditions such as cardiovascular diseases, deafness, orthopedic ailments, and other degenerative diseases can benefit greatly from newer technology-based implantable devices, especially for conditions wherein the pharmacological treatment is effective. For instance, according to the Asia Aging International Population Reports 2022, the number of people aged 65 and older is projected to rise from 730 million in 2020 to nearly 2 billion by 2060. The increasing population leads to the growing prevalence of chronic diseases. According to the National Association of Chronic Disease Directors and the Centers for Disease Control and Prevention (CDC), more than two-thirds of all deaths are caused by one or more of five chronic diseases (heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes). Thus, the increasing pool of population and rising burden of cardiovascular diseases in developing countries like India and Brazil results in increasing healthcare expenditure which proportionally drives the demand for defibrillators and also serves as an opportunity for the key players in emerging economies.
Click here to: Get Free Sample Pages of this Report
The Implantable Cardioverter Defibrillators Segment is Expected to Account for the Largest Share of the Market in 2024
Among products, in 2024, the implantable cardioverter defibrillators segment is expected to account for the largest share of the market. Implantable cardioverter defibrillator devices (ICDs) are battery-powered devices that are placed under the skin in the upper chest to keep track of the heart rate. An ICD uses electrical pulses or shocks to help control life-threatening arrhythmias, especially those that can cause a sudden cardiac arrest. The large share of the segment is attributed to factors such as wide adoption of permanent implantable cardioverter defibrillators for the prevention of sudden cardiac arrests and atrial fibrillation, rising amount of modern therapies, and increasing awareness towards healthcare. For instance, according to the American Heart Association (AHA), more than 350,000 cardiac arrests occur outside of the hospital each year. In 2020, the sudden cardiac arrest mortality in the U.S. was 436,852. If CPR or cardiac defibrillation is administered immediately after cardiac arrest, it can double or triple the chance of the patient’s survival. This should increase the demand for implantable defibrillators, driving the growth of the market.
The Adult Segment is Expected to Account for the Largest Share of the Market in 2024
Among age groups, in 2024, the adult segment is expected to account for the larger share of the market. The large share of the segment is attributed to factors such as the high prevalence of cardiovascular diseases in adults compared to pediatrics, change of lifestyle, frequent occurrence of ventricular fibrillation as compared to children, and increasing awareness of the use of portable defibrillators. According to the Centers for Disease Control and Prevention (CDC) (U.S.), in 2021, coronary artery disease was the most common type of heart disease and led to the death of 375,476 people globally. Owing to the higher demand from the adult age group, companies are developing technologically advanced defibrillators. For instance, in January 2023, Avive Solutions, Inc. (U.S.), a medtech company that develops automated external defibrillators, received FDA approval for the Avive Connect Automated External Defibrillator (AED), which combines cellular, WiFi connectivity, GPS technology, remote maintenance, and extreme portability in a handheld device. This can be used for adults who suffer from sudden cardiac arrest (SDA).
The Hospitals Segment is Expected to Account for the Largest Share of the Market in 2024
Among end users, in 2024, the hospitals segment is expected to account for the largest share of the market. The large share of the segment is attributed to factors such as the large pool of patients, including the population with cardiovascular diseases visiting the hospitals for diagnosis & treatment, owing to wide presence, easy accessibility, and better healthcare facilities in hospitals as compared to other healthcare institutions. In addition to this, increasing incidence & prevalence of cardiovascular diseases such as hypertension, bradycardia, heart failure, and cardiac arrest with a rising aging population also drive the growth of the market. The surge in hospital admissions is primarily driven by the escalating burden of chronic diseases. For instance, as of December 2023, according to the American Hospital Association (AHA), the total hospital admissions in U.S. hospitals were 33,679,935. This would also lead to an increased number of cardiovascular conditions found in patients, which could lead to death if life-saving measures are not administered immediately. This would increase the demand for implantable cardioverter defibrillators, driving the growth of the market.
North America: Largest Regional Market
The large share of the segment is attributed to the increasing incidence & prevalence of cardiovascular diseases, growing aging population, well-established healthcare system, higher healthcare expenditure, presence of large medical device manufacturers in this region, and increased accessibility & higher adoption of technically advanced medical devices for prevention, diagnosis, monitoring, and therapeutics. According to the American Hospital Association (AHA), as of 2023, there are a total of 6,120 hospitals in the U.S. The increase in the number of hospitals, coupled with advancing technologies, will further drive the market for defibrillators. For instance, in February 2024, BIOTRONIK US (U.S.), a subsidiary of Biotronik Se & Co., Kg (Germany), is moving to adopt new technologies in the proprietary DX models. This technology is the new single-chamber ICD implant, which has been known to provide better diagnostics and decrease complication risks in clinical trials as compared to traditional high-voltage systems.
Key Players
The report includes a competitive landscape based on an extensive assessment of the market based on product and end user. The report also provides insights into the presence of major market players and their key growth strategies in the last three to four years.The key players profiled in the defibrillator market report are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se & Co., Kg (Germany), LivaNova plc (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co., Ltd. (Japan), Schiller AG (Switzerland), and ZOLL Medical Corporation (U.S.).
Report Summary:
|
Particular |
Details |
|
Page No |
~220 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
6.9% |
|
Market Size (Value) |
$22.76 billion by 2031 |
|
Segments Covered |
By Product
By Age Group
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
|
Key Companies |
Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se & Co., Kg (Germany), LivaNova plc (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co., Ltd. (Japan), Schiller AG (Switzerland), and ZOLL Medical Corporation (U.S.). |
Key questions answered in the report:
This market study covers the defibrillator market sizes and forecasts based on product, end user, and geography. It also provides the value analysis of various segments and sub-segments of the global defibrillator market at country levels.
The defibrillator market is projected to reach $22.76 billion by 2031, at a CAGR of 6.9% during the forecast period.
The implantable cardioverter defibrillators segment is expected to account for the largest share of the market in 2024. Factors such as the wide adoption of permanent implantable cardioverter defibrillators for the prevention of sudden cardiac arrests and atrial fibrillation, rising modern therapies, and increasing awareness of healthcare are supporting the market's growth.
The hospitals segment is expected to account for the largest share of the cardioverter defibrillator devices market in 2024. The largest share of this segment is attributed to factors such as the large pool of patients, including the population with cardiovascular diseases visiting the hospitals for diagnosis & treatment of any healthcare concern, owing to the wide presence, easy accessibility, and better healthcare facilities in hospitals as compared to other healthcare institutions.
The growth of the cardioverter defibrillator devices market is driven by several factors, including the increasing burden of cardiovascular diseases and the rise in obesity incidence, the adoption of a sedentary lifestyle, and excessive consumption of alcohol & caffeinated products, technological advancements in defibrillator devices and increasing geriatric population. Factors such as emerging economies serve as a major opportunity for the existing market players and new entrants in the defibrillator market.
The key players profiled in the defibrillator market report are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se & Co., Kg (Germany), LivaNova plc (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co., Ltd. (Japan), Schiller AG (Switzerland), and ZOLL Medical Corporation (U.S.).
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Burden of Cardiovascular Diseases
4.2.2. Rise in Obesity, Sedentary Lifestyle, and Excessive Consumption of Alcohol & Caffeinated Products
4.2.3. Rising Geriatric Population
4.2.4. Technological Advancements in Defibrillator Devices
4.3. Restraints
4.3.1. Increase in Reported Cases of Defibrillator Malfunctions & Product Recalls
4.4. Opportunities
4.4.1. Emerging Economies
4.5. Challenges
4.5.1. Lack of Skilled Professionals
4.6. Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Porter’s Five Force Analysis
5. Global Defibrillator Market Assessment—by Product
5.1. Overview
5.2. Implantable Cardioverter Defibrillators
5.2.1. Transvenous Implantable Cardioverter Defibrillators
5.2.1.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
5.2.1.2. Dual-Chamber Implantable Cardioverter Defibrillators
5.2.1.3. Single-Chamber Implantable Cardioverter Defibrillators
5.2.2. Subcutaneous Implantable Cardioverter Defibrillators
5.3. External Cardioverter Defibrillators (ECD)
5.3.1. Manual ECD
5.3.2. Automated ECD
5.3.2.1. Semi-Automated ECD
5.3.2.2. Fully Automated ECD
5.3.3. Wearable ECD
6. Global Defibrillator Market Assessment—by Age Group
6.1. Adult
6.2. Children
7. Global Defibrillator Market Assessment—by End User
7.1. Overview
7.2. Hospital and Ambulatory Surgery Centers
7.3. Pre-Hospital/Emergency Care
7.4. Public Access Programs
7.5. Alternative/Foster Care
7.6. Homecare
8. Defibrillator Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Switzerland
8.3.7. Netherlands
8.3.8. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Market Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/ Market Ranking, by Key Players (2022)
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Medtronic plc
10.2. Boston Scientific Corporation
10.3. ZOLL Medical Corporation
10.4. Abbott Laboratories
10.5. LivaNova plc
10.6. Stryker Corporation
10.7. Koninklijke Philips N.V.
10.8. Biotronik Se & Co., Kg
10.9. Progetti Srl
10.10. Fukuda Denshi Co., Ltd.
10.11. Schiller AG
10.12. Nihon Kohden Corporation
10.13. Other Companies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 2 Global Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 3 Global Implantable Cardioverter Defibrillators Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 5 Global Transvenous Implantable Cardioverter Defibrillators Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Cardiac Resynchronization Therapy Defibrillators (CRT-D) Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Dual-chamber Implantable Cardioverter Defibrillators Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Single-chamber Implantable Cardioverter Defibrillators Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Subcutaneous Implantable Cardioverter Defibrillators Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 11 Global External Cardioverter Defibrillators Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Manual ECD Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 14 Global Automated ECD Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Semi-automated ECD Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Fully-automated ECD Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Wearable ECD Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 19 Global Defibrillator Market for Adults, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Pediatric Defibrillator Market for Children, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 22 Global Defibrillator Market for Hospital and Ambulatory Surgery Centers, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Defibrillator Market for Pre-Hospital/Emergency Care, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Defibrillator Market for Public Access Defibrillation Programs, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Defibrillator Market for Alternative/Foster Care, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Defibrillator Market for Homecare, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Defibrillator Market, by Country/Region, 2022–2031 (USD Million)
Table 28 North America: Defibrillator Market, by Country, 2022–2031 (USD Million)
Table 29 North America: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 30 North America: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 31 North America: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 32 North America: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 33 North America: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 34 North America: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 35 North America: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 36 U.S.: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 37 U.S.: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 38 U.S.: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 39 U.S.: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 40 U.S.: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 41 U.S.: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 42 U.S.: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 43 Canada: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 44 Canada: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 45 Canada: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 46 Canada: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 47 Canada: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 48 Canada: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 49 Canada: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 50 Europe: Defibrillator Market, by Country/Region, 2022–2031 (USD Million)
Table 51 Europe: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 52 Europe: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 53 Europe: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 54 Europe: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 55 Europe: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 56 Europe: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 57 Europe: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 58 Germany: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 59 Germany: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 60 Germany: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 61 Germany: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 62 Germany: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 63 Germany: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 64 Germany: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 65 France: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 66 France: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 67 France: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 68 France: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 69 France: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 70 France: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 71 France: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 72 U.K.: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 73 U.K.: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 74 U.K.: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 75 U.K.: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 76 U.K.: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 77 U.K.: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 78 U.K.: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 79 Italy: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 80 Italy: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 81 Italy: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 82 Italy: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 83 Italy: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 84 Italy: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 85 Italy: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 86 Spain: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 87 Spain: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 88 Spain: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 89 Spain: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 90 Spain: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 91 Spain: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 92 Spain: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 93 Switzerland: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 94 Switzerland: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 95 Switzerland: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 96 Switzerland: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 97 Switzerland: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 98 Switzerland: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 99 Switzerland: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 100 Netherlands: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 101 Netherlands: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 102 Netherlands: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 103 Netherlands: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 104 Netherlands: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 105 Netherlands: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 106 Netherlands: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 107 Rest of Europe: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 108 Rest of Europe: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 109 Rest of Europe: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 110 Rest of Europe: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 111 Rest of Europe: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 112 Rest of Europe: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 113 Rest of Europe: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 114 Asia-Pacific: Defibrillator Market, by Country/Region, 2022–2031 (USD Million)
Table 115 Asia-Pacific: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 116 Asia-Pacific: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 117 Asia-Pacific: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 118 Asia-Pacific: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 119 Asia-Pacific: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 120 Asia-Pacific: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 121 Asia-Pacific: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 122 Japan: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 123 Japan: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 124 Japan: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 125 Japan: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 126 Japan: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 127 Japan: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 128 Japan: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 129 China: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 130 China: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 131 China: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 132 China: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 133 China: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 134 China: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 135 China: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 136 India: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 137 India: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 138 India: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 139 India: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 140 India: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 141 India: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 142 India: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 143 Australia: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 144 Australia: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 145 Australia: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 146 Australia: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 147 Australia: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 148 Australia: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 149 Australia: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 150 South Korea: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 151 South Korea: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 152 South Korea: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 153 South Korea: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 154 South Korea: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 155 South Korea: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 156 South Korea: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 157 Rest of Asia-Pacific: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 158 Rest of Asia-Pacific: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 159 Rest of Asia-Pacific: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 160 Rest of Asia-Pacific: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 161 Rest of Asia-Pacific: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 162 Rest of Asia-Pacific: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 163 Rest of Asia-Pacific: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 164 Latin America: Defibrillator Market, by Country/Region, 2022–2031 (USD Million)
Table 165 Latin America: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 166 Latin America: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 167 Latin America: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 168 Latin America: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 169 Latin America: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 170 Latin America: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 171 Latin America: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 172 Brazil: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 173 Brazil: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 174 Brazil: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 175 Brazil: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 176 Brazil: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 177 Brazil: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 178 Brazil: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 179 Mexico: Cardioverter Defibrillator Devices Market, by Product, 2022–2031 (USD Million)
Table 180 Mexico: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 181 Mexico: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 182 Mexico: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 183 Mexico: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 184 Mexico: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 185 Mexico: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 186 Rest of Latin America: Cardioverter Defibrillator Devices Market, by Product, 2022–2031 (USD Million)
Table 187 Rest of Latin America: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 188 Rest of Latin America: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 189 Rest of Latin America: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 190 Rest of Latin America: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 191 Rest of Latin America: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 192 Rest of Latin America: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 193 Middle East and Africa: Defibrillator Market, by Product, 2022–2031 (USD Million)
Table 194 Middle East and Africa: Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 195 Middle East and Africa: Transvenous Implantable Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 196 Middle East and Africa: External Cardioverter Defibrillators Market, by Type, 2022–2031 (USD Million)
Table 197 Middle East and Africa: Automated ECD Devices Market, by Type, 2022–2031 (USD Million)
Table 198 Middle East and Africa: Defibrillator Market, by Age Group, 2022–2031 (USD Million)
Table 199 Middle East and Africa: Defibrillator Market, by End User, 2022–2031 (USD Million)
Table 200 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global Defibrillator Market, by Product, 2024 VS. 2031 (USD Million)
Figure 8 Global Defibrillator Market, by Age Group, 2024 VS. 2031 (USD Million)
Figure 9 Global Defibrillator Market, by End User, 2024 VS. 2031 (USD Million)
Figure 10 Defibrillator Market, by Geography
Figure 11 Global Defibrillator Market, by Product, 2024 VS. 2031 (USD Million)
Figure 12 Global Defibrillator Market, by Age Group, 2024 VS. 2031 (USD Million)
Figure 13 Global Defibrillator Market, by End User, 2024 VS. 2031 (USD Million)
Figure 14 Global Defibrillator Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 15 North America: Defibrillator Market Snapshot
Figure 16 Europe: Defibrillator Market Snapshot
Figure 17 Asia-Pacific: Defibrillator Market Snapshot
Figure 18 Latin America: Defibrillator Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 20 Global Defibrillator Market: Competitive Benchmarking, by Product
Figure 21 Global Defibrillator Market: Competitive Dashboard
Figure 22 Global Defibrillator Market: Market Share Analysis/Market Ranking (2023)
Figure 23 Medtronic plc: Financial Overview (2022)
Figure 24 Boston Scientific Corporation: Financial Overview (2023)
Figure 25 Abbott Laboratories: Financial Overview (2023)
Figure 26 LivaNova plc: Financial Overview (2023)
Figure 27 Stryker Corporation: Financial Overview (2023)
Figure 28 Koninklijke Philips N.V.: Financial Overview (2023)
Figure 29 Nihon Kohden Corporation: Financial Overview (2023)
Figure 30 Progetti Srl: Financial Overview (2022)
Figure 31 Fukuda Denshi Co., Ltd.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Dec-2017
Published Date: Aug-2018
Published Date: Jan-2023
Published Date: Feb-2023
